|
2022 Journal Article Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection ModelIslam, Kamrul, Sime, Fekade B., Wallis, Steven C., Bauer, Michelle J., Naicker, Saiyuri, Won, Hayoung, Zowawi, Hosam M., Choudhury, Md Abu, Shirin, Tahmina, Habib, Zakir H., Harris, Patrick N. A., Flora, Meerjady S. and Roberts, Jason A. (2022). Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model. Antimicrobial Agents and Chemotherapy, 66 (9), e0016222. doi: 10.1128/aac.00162-22 |
|
2022 Journal Article Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase-producing versus non-producing Escherichia coli in a hollow-fibre infection modelIslam, Kamrul, Sime, Fekade B., Bauer, Michelle J., Forde, Brian M., Wallis, Steven C., Harris, Patrick, Naicker, Saiyuri, Shirin, Tahmina, Habib, Zakir H., Flora, Meerjady S. and Roberts, Jason A. (2022). Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase-producing versus non-producing Escherichia coli in a hollow-fibre infection model. International Journal of Antimicrobial Agents, 60 (2) 106623, 1-7. doi: 10.1016/j.ijantimicag.2022.106623 |
|
2022 Journal Article Plasma and cerebrospinal fluid population pharmacokinetics of meropenem in neurocritical care patients: a prospective two-center studyKumta, Nilesh, Heffernan, Aaron J., Cotta, Menino Osbert, Wallis, Steven C., Livermore, Amelia, Starr, Therese, Wong, Wai Tat, Joynt, Gavin M., Lipman, Jeffrey and Roberts, Jason A. (2022). Plasma and cerebrospinal fluid population pharmacokinetics of meropenem in neurocritical care patients: a prospective two-center study. Antimicrobial Agents and Chemotherapy, 66 (8) e0014222, 1-12. doi: 10.1128/aac.00142-22 |
|
2022 Journal Article Plasma and interstitial fluid pharmacokinetics of prophylactic cefazolin in elective bariatric surgery patientsRyan, Rochelle L., Jackson, Dwane, Hopkins, George, Eley, Victoria, Christensen, Rebecca, Van Zundert, Andre A. J., Wallis, Steven C., Lipman, Jeffrey, Parker, Suzanne L. and Roberts, Jason A. (2022). Plasma and interstitial fluid pharmacokinetics of prophylactic cefazolin in elective bariatric surgery patients. Antimicrobial Agents and Chemotherapy, 66 (7), e0041922. doi: 10.1128/aac.00419-22 |
|
2022 Journal Article Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection modelIslam, Kamrul, Sime, Fekade B., Wallis, Steven C., Bauer, Michelle J., Forde, Brian M., Harris, Patrick, Shirin, Tahmina, Habib, Zakir H., Flora, Meerjady S. and Roberts, Jason A. (2022). Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model. Journal of Antimicrobial Chemotherapy, 77 (9), 2448-2455. doi: 10.1093/jac/dkac186 |
|
2022 Journal Article Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?Guerra Valero, Yarmarly C., Dorofaeff, Tavey, Coulthard, Mark G., Sparkes, Louise, Lipman, Jeffrey, Wallis, Steven C., Roberts, Jason A. and Parker, Suzanne L. (2022). Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?. Journal of Antimicrobial Chemotherapy, 77 (8), 2227-2237. doi: 10.1093/jac/dkac168 |
|
2022 Journal Article Vancomycin population pharmacokinetic modeling in children using Bayesian estimation and a Non Parametric ApproachSilveira, Anna Luísa Oliveira, da Silva Alves, Geisa Cristina, Xie, Jiao, Roberts, Jason A. and Sanches, Cristina (2022). Vancomycin population pharmacokinetic modeling in children using Bayesian estimation and a Non Parametric Approach. Brazilian Journal of Pharmaceutical Sciences, 58 e19313, 1-7. doi: 10.1590/s2175-97902020000X2e19313 |
|
2022 Journal Article Monkeypox infection presenting as genital rash, Australia, May 2022Hammerschlag, Yael, MacLeod, Gina, Papadakis, Georgina, Sanchez, Asiel Adan, Druce, Julian, Taiaroa, George, Savic, Ivana, Mumford, Jamie, Roberts, Jason, Caly, Leon, Friedman, Deborah, Williamson, Deborah A., Cheng, Allen C. and McMahon, James H. (2022). Monkeypox infection presenting as genital rash, Australia, May 2022. Eurosurveillance, 27 (2) 22. doi: 10.2807/1560-7917.ES.2022.27.22.2200411 |
|
2022 Journal Article Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)Cheng, Vesa, Abdul-Aziz, Mohd H., Burrows, Fay, Buscher, Hergen, Corley, Amanda, Diehl, Arne, Levkovich, Bianca J., Pellegrino, Vincent, Reynolds, Claire, Rudham, Sam, Wallis, Steven C., Welch, Susan A., Roberts, Jason A., Shekar, Kiran, Fraser, John F. and ASAP ECMO Investigators (2022). Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study). Anaesthesia Critical Care and Pain Medicine, 41 (3) 101080, 1-6. doi: 10.1016/j.accpm.2022.101080 |
|
2022 Journal Article Therapeutic drug monitoring and prolonged infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa infections: An observational studyNavarrete-Rouco, María Eugenia, Luque, Sònia, Sorlí, Luisa, Benítez-Cano, Adela, Roberts, Jason A. and Grau, Santiago (2022). Therapeutic drug monitoring and prolonged infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa infections: An observational study. European Journal of Drug Metabolism and Pharmacokinetics, 47 (4), 561-566. doi: 10.1007/s13318-022-00772-x |
|
2022 Journal Article Peace, not war in Ukraine or anywhere else, pleaseLefrant, Jean-Yves, Pirracchio, Romain, Benhamou, Dan, Fischer, Marc-Olivier, Njeim, Rosanna, Allaouchiche, Bernard, Bastide, Sophie, Biais, Matthieu, Bouvet, Lionel, Brissaud, Olivier, Brull, Sorin J., Capdevila, Xavier, Clausen, Nicola, Cuvillon, Philippe, Dadure, Christophe, David, Jean-Stéphane, Du, Bin, Einav, Sharon, Eley, Victoria, Forget, Patrice, Fujii, Tomoko, Godier, Anne, Gopalan, Dean P., Hamada, Sophie, Hasanin, Ahmed, Joannes-boyau, Olivier, Kerever, Sébastien, Kipnis, Éric, Kolodzie, Kerstin ... Bouaziz, Hervé (2022). Peace, not war in Ukraine or anywhere else, please. Anaesthesia Critical Care and Pain Medicine, 41 (3) 101068, 101068. doi: 10.1016/j.accpm.2022.101068 |
|
2022 Journal Article Epidemiology and microbiology of severe community‐acquired pneumonia in Central Australia: a retrospective studyTsai, Danny, Chiong, Fabian, Secombe, Paul, Hnin, Khin Moe, Stewart, Penny, Goud, Rajendra, Woodman, Richard, Lipman, Jeffrey, Roberts, Jason and Hewagama, Saliya (2022). Epidemiology and microbiology of severe community‐acquired pneumonia in Central Australia: a retrospective study. Internal Medicine Journal, 52 (6), 1048-1056. doi: 10.1111/imj.15171 |
|
2022 Journal Article Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patientsSetiawan, Eko, Abdul-Aziz, Mohd-Hafiz, Cotta, Menino Osbert, Susaniwati, Susaniwati, Cahjono, Heru, Sari, Ika Yunita, Wibowo, Tjipto, Marpaung, Ferdy Royland and Roberts, Jason A. (2022). Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients. Scientific Reports, 12 (1) 8930, 1-11. doi: 10.1038/s41598-022-12627-1 |
|
2022 Journal Article Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover DocumentSime, Fekade Bruck, Wallis, Steven, Jamieson, Conor, Hills, Tim, Gilchrist, Mark, Santillo, Mark, Seaton, R Andrew, Drummond, Felicity and Roberts, Jason (2022). Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document. European Journal of Hospital Pharmacy, 30 (e1), ejhpharm-2022. doi: 10.1136/ejhpharm-2022-003286 |
|
2022 Journal Article Multicenter population pharmacokinetic study of unbound ceftriaxone in critically ill patientsHeffernan, Aaron J., Sime, Fekade B., Kumta, Nilesh, Wallis, Steven C., McWhinney, Brett, Ungerer, Jacobus, Wong, Gloria, Joynt, Gavin M., Lipman, Jeffrey and Roberts, Jason A. (2022). Multicenter population pharmacokinetic study of unbound ceftriaxone in critically ill patients. Antimicrobial Agents and Chemotherapy, 66 (6), e0218921. doi: 10.1128/aac.02189-21 |
|
2022 Journal Article Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically-ill patientsWicha, Sebastian G., Mair, Andrea, Chiriac, Ute, Frey, Otto R., Fuchs, Thomas, Gaasch, Max, Hagel, Stefan, Richter, Daniel C., Roberts, Jason A., Röhr, Anka C., Weigand, Markus A. and Brinkmann, Alexander (2022). Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically-ill patients. International Journal of Antimicrobial Agents, 59 (5) 106572, 106572. doi: 10.1016/j.ijantimicag.2022.106572 |
|
2022 Journal Article Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (Intensive Care Medicine, (2022), 48, 3, (311-321), 10.1007/s00134-021-06609-6)Hagel, Stefan, Bach, Friedhelm, Brenner, Thorsten, Bracht, Hendrik, Brinkmann, Alexander, Annecke, Thorsten, Hohn, Andreas, Weigand, Markus Alexander, Michels, Guido, Kluge, Stefan, Nierhaus, Axel, Jarczak, Dominik, König, Christina, Weismann, Dirk, Frey, Otto, Witzke, Dominic, Müller, Carsten, Bauer, Michael, Kiehntopf, Michael, Neugebauer, Sophie, Lehmann, Thomas, Roberts, Jason A., Pletz, Mathias W., Braune, Anke, Schmidt, Karsten, Motsch, Johann, Pinder, Nadine, Richter, Daniel, Schlattmann, Peter ... Chkirni, Hicham (2022). Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (Intensive Care Medicine, (2022), 48, 3, (311-321), 10.1007/s00134-021-06609-6). Intensive Care Medicine, 48 (5), 646-647. doi: 10.1007/s00134-022-06668-3 |
|
2022 Journal Article Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysisEzure, Yukiko, Rico, Veronica, Paterson, David L., Hall, Lisa, Harris, Patrick N. A., Soriano, Alex, Roberts, Jason A., Bassetti, Matteo, Roberts, Matthew J., Righi, Elda and Wright, Hugh (2022). Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis. Open Forum Infectious Diseases, 9 (5) ofaa480, ofaa480. doi: 10.1093/ofid/ofaa480 |
|
2022 Journal Article Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection modelAvent, Minyon L., McCarthy, Kate L., Sime, Fekade B., Naicker, Saiyuri, Heffernan, Aaron J., Wallis, Steven C., Paterson, David L. and Roberts, Jason A. (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. Microbiology Spectrum, 10 (3), e0052522. doi: 10.1128/spectrum.00525-22 |
|
2022 Journal Article Use of the hollow-fiber infection model to measure the effect of combination therapy of septic shock exposures of Meropenem and Ciprofloxacin against intermediate and resistant Pseudomonas aeruginosa clinical IsolatesKarabasevic, Natalija, Roberts, Jason A., Stronach, Luke, Naicker, Saiyuri, Wallis, Steven C., Sjövall, Fredrik and Sime, Fekade (2022). Use of the hollow-fiber infection model to measure the effect of combination therapy of septic shock exposures of Meropenem and Ciprofloxacin against intermediate and resistant Pseudomonas aeruginosa clinical Isolates. Antimicrobial Agents and Chemotherapy, 66 (5) e0214021, e0214021. doi: 10.1128/aac.02140-21 |
